Future of the Minimal Residual Disease Testing Market: Insights, Developments, and Strategic Overview
Ideal for market intelligence professionals and business strategists, this research uncovers where growth is headed in the minimal residual disease testing industry. Minimal Residual Disease Testing Market Valuation Forecast: What Will The Market Be Worth By 2025? The minimal residual disease testing market size has grown rapidly in recent years. It will grow from $1.59 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to advancements in cancer research, treatment monitoring needs, clinical evidence, regulatory support, patient outcome improvement. The minimal residual disease testing market size is expected to see rapid growth in the next few years. It will grow to $2.91 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing cancer incidence, therapeutic advancements, precision medicine trends, shift toward e...